Sharp margin drop
EBITDA margin dropped 6.5 percentage points in a single year, from 24.6% to 18.1% — worth investigating.
Importance 70 / 95 · anomaly
The strongest observations the engine found, ranked. Every line is generated from the filed numbers by a fixed rule — no opinion, no estimate.
EBITDA margin dropped 6.5 percentage points in a single year, from 24.6% to 18.1% — worth investigating.
Importance 70 / 95 · anomaly
Revenue grew 16.0% but profit grew 9.3%, so the company kept less of each rupee of revenue as profit.
Importance 62 / 95 · growth
Over 3 years profit compounded at 23.1% a year while the stock fell 1.7% a year — the FY2023 base was somewhat depressed, so part of this is recovery rather than trend.
Importance 55 / 95 · business vs stock
Classified by the exchange under Commodities › Construction Materials › Cement & Cement Products › Cement & Cement Products.
Peer set used on this page: 3 cement & cement products.
Revenue grew 1.5% a year over 3 years, from ₹38,937 cr in FY2023 to ₹40,656 cr in FY2026. Net profit grew 23.1% a year over the same period.
Revenue grew 16.0% but EBITDA margin fell 6.5 percentage points to 18.1%, so the company kept less of each rupee of revenue as operating profit.
Rule REVENUE_UP_MARGIN_DOWN
Revenue grew 16.0% but profit grew 9.3%, so the company kept less of each rupee of revenue as profit.
Revenue grew 16.0% year on year (FY2025 → FY2026).
In Q2 FY27 (Jul–Sep 2026), revenue was ₹9,197 cr (up 0.2% on the same quarter last year) and net profit ₹236 cr (down 89.7%).
Quarterly results, the trailing-twelve-months snapshot, and verified corporate actions — kept separate from each other and from the annual story above. Every figure traces to a filed number; nothing here is external news or commentary.
Q2 FY27 net profit was ₹236 cr, down 89.7% from ₹2,302 cr a year earlier.
Rule QTR_PROFIT_GROWTH_YOY
Q2 FY27 net profit declined 89.7% while revenue grew 0.2% vs the same quarter last year — a gap of 90.0 percentage points.
Rule QTR_PROFIT_VS_REVENUE_GROWTH
Q2 FY27 EBIT was ₹452 cr, down 60.1% from ₹1,133 cr a year earlier.
Rule QTR_OPERATING_PERFORMANCE_CHANGE_YOY
| Quarter | Revenue | YoY | Net profit | YoY | Net margin |
|---|---|---|---|---|---|
| Q3 FY25 | 9,329 | +14.8% | 2,620 | +140.5% | 28.1% |
| Q4 FY25 | 9,889 | +11.2% | 1,282 | −16.0% | 13.0% |
| Q1 FY26 | 10,289 | +23.8% | 970 | +22.8% | 9.4% |
| Q2 FY26 | 9,174 | +22.1% | 2,302 | +386.9% | 25.1% |
| Q3 FY26 | 10,277 | +10.2% | 367 | −86.0% | 3.6% |
| Q4 FY26 | 10,915 | +10.4% | 1,857 | +44.9% | 17.0% |
| Q1 FY27 | 9,500 | −7.7% | 660 | −31.9% | 6.9% |
| Q2 FY27 | 9,197 | +0.2% | 236 | −89.7% | 2.6% |
Trailing twelve months to 30 Sept 2026 · sum of the last 4 contiguous quarters
EBITDA margin was 18.1% in FY2026, against 15.1% in FY2023. ROE was 8.3% and ROCE 5.6% in FY2026.
Margin and return trends are shown above.
It had little or no debt in FY2026 (debt-to-equity 0.00x). Operating cash flow was 0.95x net profit.
Leverage and cash generation over the loaded history are shown above.
Within its 3-company Cement & Cement Products peer group, it ranks 2 of 3 on return on equity and 2 of 3 on EBITDA margin. Its P/E of 31.6 compares with a peer median of 31.6.
Ranked against 3 cement & cement products (FY2026, consolidated). No peer-relative rule fired for this company.
AMBUJACEM · 3rd of 3 · set median 16.5%
AMBUJACEM · 2nd of 3 · set median 18.1%
AMBUJACEM · 2nd of 3 · set median 8.3%
AMBUJACEM · 2nd of 3 · set median 31.6×
On the trailing twelve months. Last full year: P/E 17.5× · P/S 2.4× · ROE 8.3%. TTM and full-year profit and EBITDA differ by more than 15% — a one-off in a recent quarter is moving the trailing figure; weigh it against the full year.
The share price is down 28.2% over 1 year, down 5.0% over 3 years (−1.7% a year) and down 0.4% over 5 years (−0.1% a year). These are price changes excluding dividends, adjusted for splits and bonuses, to 20 Nov 2026; it is 30.1% below its 52-week high.
Over 3 years profit compounded at 23.1% a year while the stock fell 1.7% a year — the FY2023 base was somewhat depressed, so part of this is recovery rather than trend.
Rule STOCK_LAGGED_EARNINGS · rebound
Price-action indicators as of 2026-11-20. Secondary to the fundamentals above — included for timing context, not as a signal.
Observations the engine tagged watch or deteriorating — prompts for your own research, not conclusions.
The full statements, kept deliberately secondary. Every figure traces to a BSE Integrated Filing (inline XBRL); ratios are recomputed from the normalised facts.
| Metric | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Revenue | 38,937 | 33,160 | 35,045 | 40,656 |
| Total income | 39,675 | 34,326 | 37,699 | 41,490 |
| EBITDA | 5,860 | 7,566 | 8,625 | 7,373 |
| Profit before tax | 3,701 | 5,878 | 5,909 | 3,279 |
| Net profit | 3,024 | 4,738 | 5,158 | 5,637 |
| EPS (₹) | 13.0 | 18.0 | 17.0 | 19.1 |
| Net worth | 38,757 | 50,846 | 63,811 | 71,846 |
| Total debt | 48 | 37 | 27 | 53 |
| Operating cash flow | 735 | 5,646 | 3,295 | 5,362 |
| Free cash flow | −3,331 | 1,685 | −5,296 | −983 |
| Ratio | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Growth | ||||
| Revenue growth YoY | — | -14.8 | 5.7 | 16.0 |
| Profit growth YoY | — | 56.7 | 8.9 | 9.3 |
| Profitability | ||||
| EBITDA margin % | 15.1 | 22.8 | 24.6 | 18.1 |
| Net margin % | 7.6 | 13.8 | 13.7 | 13.6 |
| Return on equity % | 7.8 | 10.6 | 9.0 | 8.3 |
| Return on capital % | 10.9 | 13.3 | 10.7 | 5.6 |
| Leverage & cash | ||||
| Debt to equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash flow ÷ profit | 0.24 | 1.19 | 0.64 | 0.95 |
| Current ratio | 1.67 | 2.15 | 1.42 | 1.05 |